Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing
by
van der Wilt, Gert Jan
, Veltman, Joris A
, Grutters, Janneke P C
, van Nimwegen, Kirsten J M
, van Soest, Ronald A
, Nelen, Marcel R
, Vissers, Lisenka E L M
in
Capital costs
/ Clinical medicine
/ Cost analysis
/ Costs and Cost Analysis
/ Data analysis
/ Data interpretation
/ Data processing
/ Funding
/ Genomes
/ High-Throughput Nucleotide Sequencing - economics
/ High-Throughput Nucleotide Sequencing - trends
/ Humans
/ Maintenance costs
/ Mutation
/ Quality of life
/ R&D
/ Research & development
/ Sample preparation
/ Sequence Analysis, DNA - economics
/ Sequence Analysis, DNA - trends
2016
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing
by
van der Wilt, Gert Jan
, Veltman, Joris A
, Grutters, Janneke P C
, van Nimwegen, Kirsten J M
, van Soest, Ronald A
, Nelen, Marcel R
, Vissers, Lisenka E L M
in
Capital costs
/ Clinical medicine
/ Cost analysis
/ Costs and Cost Analysis
/ Data analysis
/ Data interpretation
/ Data processing
/ Funding
/ Genomes
/ High-Throughput Nucleotide Sequencing - economics
/ High-Throughput Nucleotide Sequencing - trends
/ Humans
/ Maintenance costs
/ Mutation
/ Quality of life
/ R&D
/ Research & development
/ Sample preparation
/ Sequence Analysis, DNA - economics
/ Sequence Analysis, DNA - trends
2016
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing
by
van der Wilt, Gert Jan
, Veltman, Joris A
, Grutters, Janneke P C
, van Nimwegen, Kirsten J M
, van Soest, Ronald A
, Nelen, Marcel R
, Vissers, Lisenka E L M
in
Capital costs
/ Clinical medicine
/ Cost analysis
/ Costs and Cost Analysis
/ Data analysis
/ Data interpretation
/ Data processing
/ Funding
/ Genomes
/ High-Throughput Nucleotide Sequencing - economics
/ High-Throughput Nucleotide Sequencing - trends
/ Humans
/ Maintenance costs
/ Mutation
/ Quality of life
/ R&D
/ Research & development
/ Sample preparation
/ Sequence Analysis, DNA - economics
/ Sequence Analysis, DNA - trends
2016
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing
Journal Article
Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing
2016
Request Book From Autostore
and Choose the Collection Method
Overview
The substantial technological advancements in next-generation sequencing (NGS), combined with dropping costs, have allowed for a swift diffusion of NGS applications in clinical settings. Although several commercial parties report to have broken the $1000 barrier for sequencing an entire human genome, a valid cost overview for NGS is currently lacking. This study provides a complete, transparent and up-to-date overview of the total costs of different NGS applications.
Cost calculations for targeted gene panels (TGP), whole exome sequencing (WES) and whole genome sequencing (WGS) were based on the Illumina NextSeq500, HiSeq4000, and HiSeqX5 platforms, respectively. To anticipate future developments, sensitivity analyses are performed.
Per-sample costs were €1669 for WGS, € 792 for WES and €333 for TGP. To reach the coveted $1000 genome, not only is the long-term and efficient use of the sequencing equipment needed, but also large reductions in capital costs and especially consumable costs are also required.
WES and TGP are considerably lower-cost alternatives to WGS. However, this does not imply that these NGS approaches should be preferred in clinical practice, since this should be based on the tradeoff between costs and the expected clinical utility of the approach chosen. The results of the present study contribute to the evaluation of such tradeoffs.
Publisher
Oxford University Press
This website uses cookies to ensure you get the best experience on our website.